Narrative review / 2014
Dietary modulation of gut microbiota via whole-plant foods, prebiotics, and probiotics may help manage cardiovascular risk.
This review summarizes evidence connecting gut microbiome activities with cardiovascular disease (CVD) and dietary modulation. Aberrant gut microbiota profiles are linked to obesity, diabetes, and non-alcoholic fatty liver disease, while microbial metabolites from choline, phosphatidylcholine, and l-carnitine directly contribute to CVD pathology. In human studies, selected bile-salt hydrolysing probiotic strains lowered blood cholesterol, and fermentable fibers and plant polyphenols appear to regulate microbial activities. The review concludes that dietary strategies modulating gut microbiota are emerging as efficacious tools for reducing CVD risk, suggesting the way to a healthy heart may be through a healthy gut.
- Study type
- Narrative review
- Who was studied
- Human and animal studies on gut microbiota and cardiovascular disease
- What was measured
- Cardiovascular disease risk, metabolic disease, insulin sensitivity, and blood cholesterol
THE PAPER
'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM, Fava F, Viola R. Proc Nutr Soc, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.